Search - tctmd.com

Displaying 201 - 220 of 1375

Sort: Relevancy | Date

News Conference News ACC 2024

Faster CAC Progression After Menopause May Warrant Intensified Therapy

L.A. McKeown

April 04, 2024

News Opinion CV Team Dispatch

April 2024 Dispatch for the CV Team

L.A. McKeown

April 01, 2024

News Conference News ACC 2024

Icosapent Ethyl Lowers CV Risk Across Lp(a) Range: REDUCE-IT

Todd Neale

March 27, 2024

News Conference News THT 2024

Smart Scale Better at Predicting HF Events Than Weight-Based Monitoring

Michael O'Riordan

March 11, 2024

News Conference News THT 2024

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

Michael O'Riordan

March 07, 2024

Presentation THT 2024

GPx -- Bloodless Blood Tests

Presenter: Javier Echenique

March 05, 2024

News Daily News

DISCHARGE Data Reassure on Use of CCTA in Older Chest-Pain Patients

Michael O'Riordan

March 04, 2024

News Daily News

High-Risk ‘Clues’ Add Heft to Calcium Scores in Primary Prevention

Michael O'Riordan

February 29, 2024

News Daily News

Living Near Bars, Restaurants Linked to Greater Likelihood of HF

L.A. McKeown

February 29, 2024

News Daily News

High Lp(a) Levels Harmful in Patients With and Without ASCVD

Michael O'Riordan

February 27, 2024

News Daily News

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

Michael O'Riordan

February 23, 2024

News Daily News

High-Protein Diets Linked to Amino Acid Activation of ASCVD Pathway

L.A. McKeown

February 21, 2024

News Daily News

Increased Lp(a) Ups CV Risk Regardless of hs-CRP Level

Yael L. Maxwell

February 15, 2024

News Daily News

Salt Substitute Slashes New Hypertension Diagnoses: DECIDE-Salt

L.A. McKeown

February 14, 2024

News Daily News

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Michael O'Riordan

February 08, 2024

News Daily News

Injectable Semaglutide Shortage Forces Physicians to Pivot

Todd Neale

February 05, 2024

News Daily News

BMI Mostly Doesn’t Impact DOACs, Except Maybe at the Extremes

Todd Neale

February 02, 2024

News Opinion CV Team Dispatch

February 2024 Dispatch for the CV Team

L.A. McKeown

February 01, 2024

News Daily News

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Michael O'Riordan

February 01, 2024

News Daily News

Less Is More: Lp(a) Much More Atherogenic Than LDL

Michael O'Riordan

January 16, 2024

Advertisement

Faster CAC Progression After Menopause May Warrant Intensified Therapy

April 2024 Dispatch for the CV Team

Icosapent Ethyl Lowers CV Risk Across Lp(a) Range: REDUCE-IT

Smart Scale Better at Predicting HF Events Than Weight-Based Monitoring

Small Study Hints at Apixaban’s Potential in LVAD-Treated Patients

GPx -- Bloodless Blood Tests

DISCHARGE Data Reassure on Use of CCTA in Older Chest-Pain Patients

High-Risk ‘Clues’ Add Heft to Calcium Scores in Primary Prevention

Living Near Bars, Restaurants Linked to Greater Likelihood of HF

High Lp(a) Levels Harmful in Patients With and Without ASCVD

Mechanism’s Mojo: ‘Obvious’ CV Therapies More Likely to Be Seen as Effective

High-Protein Diets Linked to Amino Acid Activation of ASCVD Pathway

Increased Lp(a) Ups CV Risk Regardless of hs-CRP Level

Salt Substitute Slashes New Hypertension Diagnoses: DECIDE-Salt

Evolocumab Reduces MACE in Patients With and Without Multivessel CAD: FOURIER

Injectable Semaglutide Shortage Forces Physicians to Pivot

BMI Mostly Doesn’t Impact DOACs, Except Maybe at the Extremes

February 2024 Dispatch for the CV Team

Universal Risk Tool Works Well in Both Primary and Secondary Prevention

Less Is More: Lp(a) Much More Atherogenic Than LDL

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content